Benjamin Kim is a Partner at Playground Global, where they leverage extensive experience in investment and board oversight across various biotech companies. Currently, they serve as a board observer and lead investor for multiple firms, including Insamo, Amber Bio, and Infinimmune. Benjamin earned a Doctor of Philosophy (PhD) in Bioengineering and Biomedical Engineering from Stanford University, following a Bachelor of Arts in Biochemistry from Washington University in St. Louis. Their previous roles include Innovation Team Leader at Merck KGaA and multiple positions at Playground Global, showcasing a robust career in venture capital and biotechnology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices